Cut through the noise.
Trade on the signal.

Problems at Nutex, Part Two: Misunderstood by Investors and Facing a Revenue Cliff As Schemes Unravel

Capybara Research exposes Nutex Health's alleged systematic billing fraud, revealing a 228% revenue spike, massive receivables inflation, and potential $300M markdown risk through fraudulent arbitration practices with...